Benzinga | May 13, 2021 07:13AM EDT

uniQure Presents HOPE-B Clinical Data Demonstrating Clinical Benefit in Hemophilia B Patients with Pre-existing Antibodies to AAV5 Vector

Data Show No Clinically Significant Correlation Between Pre-Existing NAbs and FIX Activity ~



~ Further Supports Potential for AAV5 Gene Therapies to be Viable Treatments in Nearly All Patients --

~ Data Presented at the American Society of Gene & Cell Therapy (ASGCT) Annual Meeting ~